Sam Brusco, Associate Editor11.15.23
Novanta, a partner to medical and advanced technology equipment makers, has begun an agreement to acquire Motion Solutions, a provider of highly engineered integrated solutions. The deal is valued at $189 million.
Motion Solutions designs and manufactures high-precision, customized subsystems and components, specializing in proprietary precision motion and advanced motion control products. The business boasts over 110 employees and has its headquarters in Irvine, Calif.
"Motion Solutions is an exciting business with intelligent subsystem competencies within attractive medical and precision medicine markets,” Novanta’s chair and CEO Matthijs Glastra told the press. “The business adds complementary motion subsystem solutions to Novanta’s product portfolio, giving us greater exposure to leading OEM customers in markets such as spatial biology, genomics, proteomics, medical robotics, and lab automation. In addition, the transaction gives us opportunity to design unique solutions for our mutual OEM customer base combining Novanta’s and Motion Solutions’ capabilities.”
Motion Solutions expects to generate about $85 million of revenue in 2023.
Novanta has expertise in precision medicine and manufacturing, medical solutions, robotics, and automation. The company engineers core components and subsystems for its medical and advanced industrial customers’ applications.
Motion Solutions designs and manufactures high-precision, customized subsystems and components, specializing in proprietary precision motion and advanced motion control products. The business boasts over 110 employees and has its headquarters in Irvine, Calif.
"Motion Solutions is an exciting business with intelligent subsystem competencies within attractive medical and precision medicine markets,” Novanta’s chair and CEO Matthijs Glastra told the press. “The business adds complementary motion subsystem solutions to Novanta’s product portfolio, giving us greater exposure to leading OEM customers in markets such as spatial biology, genomics, proteomics, medical robotics, and lab automation. In addition, the transaction gives us opportunity to design unique solutions for our mutual OEM customer base combining Novanta’s and Motion Solutions’ capabilities.”
Motion Solutions expects to generate about $85 million of revenue in 2023.
Novanta has expertise in precision medicine and manufacturing, medical solutions, robotics, and automation. The company engineers core components and subsystems for its medical and advanced industrial customers’ applications.